{"name":"Pikavation Therapeutics, Inc.","slug":"pikavation-therapeutics-inc","ticker":"","exchange":"","domain":"pikavation.com","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"Pharma / Biotech","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"SNV4818","genericName":"SNV4818","slug":"snv4818","indication":"Other","status":"phase_1"}]}],"pipeline":[{"name":"SNV4818","genericName":"SNV4818","slug":"snv4818","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiiwFBVV95cUxPWDVEZ0VCRW93QVE2YVJvWmVXR0JOdXNwaWxBVnFCUW1IRkg1Q3l3Nm9ZNVVocHJJUi1GUjF6MHBoZWJyZG5jTFJRQWxYZVJHMllpcjZUT3JCc3ZqSlhyQ1p0aGphUU9sZi14YmNDRzMwWnc2TE52NmlPMmFhMzN2R3dIVjQxeTl5WHdB0gGQAUFVX3lxTE9vdDRvQ3F5dFdaem0yUkFGTVFRdEI0ZE5EeWxtUzRiTk9GQTVxcllvenpMMEdQYm1ERWxiRUJORmtFUTU1WFY5Q2ZlaGJ3LTJzUnprZGVfZUJWUzJIT0JaV01iZ2VNSlhLTko5TWp1RFFEbFQ2dThPTTFvVFpXMGwwWWgtVENvWHFwd3ZVUTdLcA?oc=5","date":"2026-03-27","type":"deal","source":"CNBC","summary":"Novartis shells out $2 billion for immunology biotech Excellergy, in second multi-billion dollar deal in a week - CNBC","headline":"Novartis shells out $2 billion for immunology biotech Excellergy, in second multi-billion dollar deal in a week","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2026-03-25","type":"deal","source":"Indian Pharma Post","summary":"Novartis strikes $3 billion deal to acquire next-gen breast cancer drug - Indian Pharma Post","headline":"Novartis strikes $3 billion deal to acquire next-gen breast cancer drug","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivAFBVV95cUxNZ2tZd0Q5RWRocVJCMHg4dkVDZFVSa2hsWjRJeXNVVm1HLUp6UHo0a2lMdEgzMl9hOWtJRjZnVUJHRmdCcUtqUl9PXzJzbENUdXNHRTQ5WkVIVnlrZHVFYVJXSmlHV0dBNkFlOXR6dHFCa1hpZnE0N3B0dFh1RTZXdFdOZF9FVHJjWTk3aXNTZkl4U0tDY2UteXo1YWdEdGNhTU5uM3VfamdZeVFlZHdldmd2dlB2ZmQ4bnpLTg?oc=5","date":"2026-03-23","type":"pipeline","source":"MedCity News","summary":"Why Novartis Is Paying $2B for a Cancer Drug That Hits the Same Target as One of Its Own Products - MedCity News","headline":"Why Novartis Is Paying $2B for a Cancer Drug That Hits the Same Target as One of Its Own Products","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirgFBVV95cUxOZm1Qb0E5OGYwNGNQM1poMVMtZTFWUWl2UWJxUERmQXF2LVRoSE11WUlscEVqWlg5YVpoLXBxWWVaUmUtbDJFYUZBeG8zMmhXOVRoTlc1Vms3ZWl0a0UtU0dyaGlocGtYZXFzdmpaTmpfaFh5SFprX3VWa0FyME9NVVYzVTgtTmZQYy00eGpOVHV1alVGaTVjc1AwaTRoRk1xbUdJVU9pU2JXZDc0blE?oc=5","date":"2026-03-22","type":"deal","source":"Genetic Engineering and Biotechnology News","summary":"Novartis Acquires Pikavation for Up to $3B, Expanding Cancer Pipeline - Genetic Engineering and Biotechnology News","headline":"Novartis Acquires Pikavation for Up to $3B, Expanding Cancer Pipeline","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMib0FVX3lxTE9RWnUwbnBwaGkyUmRkMlY5dlA5WHZJLW9FbzRUam5SM05rc0E5R1ljSEVFb1plVnotM3c4M3hKWlFuSDlnLVZzanV2MEFYTlBJM2V5LVNtRHRhbTJVZEZVa2hoVldxMWlsLW9OSm0ySQ?oc=5","date":"2026-03-20","type":"pipeline","source":"medwatch.com","summary":"Novartis pours billions into breast cancer drug candidates from US-based Pikavation - medwatch.com","headline":"Novartis pours billions into breast cancer drug candidates from US-based Pikavation","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMixgFBVV95cUxQdjFfNDBOcS1zOWxXa08tbVhtbW1ORXJyb21LdUZPRGV4RGoxeFpTUXRUYmFpZ0U4cVZDaXllS3U2b2VFU1ZwV05KR3JUcVFxSEJ3NFA3OTQzcVlpdUNwbjFXUXI0V1o4bnctY0Q2NmxqZGVHVzc0bGd4a05wN2o1SHVoMWdaOGF3U2JJSHM1Zlc1VFdnN2kxQzBLRmkwTENxSHA4ZnlkVnBqdEUzRjRMMU5SZ1ptSXdpZFNFdGo4UDJhUi1sT0E?oc=5","date":"2026-03-20","type":"deal","source":"AD HOC NEWS","summary":"Novartis AG Stock Surges on $3 Billion Pikavation Therapeutics Acquisition Deal - AD HOC NEWS","headline":"Novartis AG Stock Surges on $3 Billion Pikavation Therapeutics Acquisition Deal","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi3gFBVV95cUxPbXBGY2toZ1liczV5bVRZTW9JbkFiVmhrY2J1WG52RXJjTWFJNjk0b2hrRTJWUWgyU2tZN0RUczRQbE9Fa3lzek55SmNobFg1cmloQ0RuRUJIN2tCX2h0ay1MTGJ2em1hUUYwc0xoT2RmMno5bGx0bERZSU9rNjFSdUZrdzc0YnNjZGctb3RyXzRuUmxveTU3WWJUR0JHVjJkVGVqV2NpSU1zV3pkamZrQkVWX3ZqQjVxWFFlaUdpWU9BSXdPMFNoRFZNbE90ZjJVMWo3QjNYTVc5WjlWdlE?oc=5","date":"2026-03-20","type":"deal","source":"Business Wire","summary":"Novartis to Acquire Synnovation Therapeutics’ Pan-Mutant Selective PI3Kα Inhibitor Program - Business Wire","headline":"Novartis to Acquire Synnovation Therapeutics’ Pan-Mutant Selective PI3Kα Inhibitor Program","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimwFBVV95cUxQdjNXMDdRc05HdllsaFFlZF9wSEVTVU5KbG83QnVzYllPZDNqMGhyYXFlcGw5NldzM1RUZEdkcDgxSms5THJYTlBnNm9RLVZxejl1MUswcGhNZ2MzSm5XT2YtQlFCZWpSTG95Sm15RWpCaHh2YVR6WXlBSWd2X1RGNkkzVHJLM2lGZnZjSE5iSHM3a2dOUUd1NThxNA?oc=5","date":"2026-03-20","type":"pipeline","source":"BioPharma Dive","summary":"Novartis pays $2B to land a startup’s breast cancer drug - BioPharma Dive","headline":"Novartis pays $2B to land a startup’s breast cancer drug","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi6wFBVV95cUxNXzJNR3FNRzBMeWNUMGZIR0l6dEhOU2FVb09hNjY1Z21kb1N3dzcxNzBFVl9xUVZTQi1wWUl4N0NrUlM5ZnpjRVVPRmRaRk5XUk51aHR1amtvMkk0VWFTLUxOcjhHLXk5M0dERlpEaFQ4T1UySDJRTlZzS2pXSGx0a0FfMm9qVVI1eTlHYVM0OE10Z281SEFvTUExWl9ob2l0UFZ0YmNfNW5rQmhFeFpMYjdLU2NLWktsVXhYOGJkWVp2VThCY2xMNnV5cFd0eXdmaXl0WHpJaXpEa2lzcjR2NU05VTJzLUxPLThB?oc=5","date":"2026-03-20","type":"deal","source":"Pharmaceutical Executive","summary":"Pharma M&A Roundup: Novartis to Acquire Pan-Mutant-Selective PI3Kα Inhibitor from Synnovation Therapeutics, Collegium to Acquire Azstarys from Corium Therapeutics - Pharmaceutical Executive","headline":"Pharma M&A Roundup: Novartis to Acquire Pan-Mutant-Selective PI3Kα Inhibitor from Synnovation Therapeutics, Collegium to","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_1":1},"enrichmentLevel":2,"visitCount":3,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}